Teleflex Incorporated Stock Intrinsic Value – Teleflex Stock Rises Thursday, Outperforms Market by Wide Margin
November 4, 2023
🌥️Trending News
Thursday was a successful day for Teleflex Incorporated ($NYSE:TFX) stock, as the company outperformed the market by a wide margin. Teleflex Incorporated is a global provider of medical technologies designed to improve the health and quality of people’s lives. The company offers a full range of products for critical care and acute care, including vascular access, anesthesia, respiratory care, cardiac care, urology, and surgery. Teleflex Incorporated also provides specialty and consumer medical products in the areas of orthopedics, vascular intervention, endoscopy, and neonatal care.
Investors have been keeping an eye on the company, as the stock has recently seen a surge in trading volume and has outperformed the market in the past five trading sessions. This positive momentum in Teleflex Incorporated stock is likely to continue in the near future.
Share Price
TELEFLEX INCORPORATED stock rose Thursday, outperforming the market by a wide margin. On Friday, the stock opened at $211.9 and closed at $211.0, up by 0.9% from its prior closing price of 209.2. This signifies a strong performance for the company’s stock, which is a good sign for investors. Despite some volatility in the market, TELEFLEX INCORPORATED showed resilience and managed to make gains.
This signals that there is still confidence in the company’s long-term prospects and that the stock could continue to rise in the near future. The company’s strong performance on Thursday is indicative of its ability to weather tough market conditions. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Teleflex Incorporated. More…
| Total Revenues | Net Income | Net Margin |
| 2.96k | 403.81 | 14.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Teleflex Incorporated. More…
| Operations | Investing | Financing |
| 469.99 | -258.43 | 258.91 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Teleflex Incorporated. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.49k | 3.18k | 89.7 |
Key Ratios Snapshot
Some of the financial key ratios for Teleflex Incorporated are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 5.7% | 6.8% | 19.0% |
| FCF Margin | ROE | ROA |
| 12.8% | 8.3% | 4.7% |
Analysis – Teleflex Incorporated Stock Intrinsic Value
At GoodWhale, we have conducted a thorough analysis of the financials of TELEFLEX INCORPORATED. Using our proprietary Valuation Line, we have determined that the fair value of a TELEFLEX INCORPORATED share is around $284.5. However, currently TELEFLEX INCORPORATED stock is being traded at $211.0, representing a 25.8% discount to its fair value. Therefore, we believe this stock is currently undervalued and a good opportunity for investors. More…
Peers
Teleflex Inc., a leading global provider of medical technologies, offers a broad range of products and services for use in critical care and surgery. The company’s products are used by hospitals and other healthcare facilities worldwide. Teleflex’s competitors include Delta Asia International Corp, Meihua International Medical Technologies Co Ltd, and Shanghai Sanyou Medical Co Ltd.
– Delta Asia International Corp ($TPEX:6762)
Daiwa-Asia International Corp is a leading provider of financial services in Asia. The company offers a wide range of products and services, including banking, insurance, asset management, and securities brokerage. Daiwa-Asia has a strong presence in the region, with operations in Hong Kong, Singapore, Taiwan, China, and Japan. The company is listed on the Tokyo Stock Exchange and has a market capitalization of 5.54 billion as of 2022. Daiwa-Asia reported a return on equity of 11.54% for the year ended March 31, 2022.
– Meihua International Medical Technologies Co Ltd ($NASDAQ:MHUA)
Meihua International Medical Technologies Co Ltd is a Chinese medical technology company. It has a market cap of 191.52M as of 2022 and a Return on Equity of 16.31%. The company develops, manufactures, and sells medical devices and equipment. Its products include stents, catheters, and other cardiovascular products.
– Shanghai Sanyou Medical Co Ltd ($SHSE:688085)
Shanghai Sanyou Medical Co Ltd is a medical company with a market cap of 7.06B as of 2022 and a Return on Equity of 8.19%. The company specializes in the manufacture and sale of medical equipment and supplies. It is headquartered in Shanghai, China.
Summary
Teleflex Incorporated (TFX) saw its stock price rise Thursday, outperforming the wider market. The company is a diversified global provider of medical technologies designed to improve the health and quality of people’s lives. Analysts suggest that the stock surge was likely driven by strong earnings growth, an expanding product portfolio, and upbeat outlooks from leading industry analysts. Teleflex’s long-term prospects remain positive as it continues to focus on providing innovative solutions to meet customer needs and drive revenue growth.
In addition, the company is seeking to expand its global reach and capitalize on new markets, which could lead to further stock gains in the future. Overall, investors appear optimistic about Teleflex’s financial prospects and the stock remains a favorable investment option for those seeking to capitalize on its long-term growth trajectory.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
